AEON Biopharma Inc.
(AEON)
undefined
undefined%
At close: undefined
0.19
1.66%
After-hours Jan 08, 2025, 08:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY22 | FY21 | FY20 | FY19 |
| Net Income | -52.56M | -55.64M | -32.91M | 160.31M |
| Depreciation & Amortization | 68.00K | 3.00K | n/a | 1.26M |
| Stock-Based Compensation | 5.89M | 5.22M | 4.79M | 5.25M |
| Other Working Capital | -345.00K | 2.31M | 933.00K | 3.54M |
| Other Non-Cash Items | -3.00K | 19.38M | 17.21M | -196.96M |
| Deferred Income Tax | 4.75M | 1.18M | n/a | -14.64M |
| Change in Working Capital | 6.27M | 1.42M | 1.45M | 50.00K |
| Operating Cash Flow | -35.58M | -28.43M | -9.46M | -44.73M |
| Capital Expenditures | -306.00K | -170.00K | n/a | -1.69M |
| Acquisitions | n/a | n/a | -1.26M | -36.53M |
| Purchase of Investments | n/a | n/a | n/a | -89.07M |
| Sales Maturities Of Investments | n/a | n/a | n/a | 10.00M |
| Other Investing Acitivies | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -306.00K | -170.00K | -1.26M | -117.29M |
| Debt Repayment | 40.51M | 15.00M | 25.11M | 9.68M |
| Common Stock Repurchased | n/a | n/a | n/a | -64.00K |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | -1.44M | -541.00K | -14.20M |
| Financial Cash Flow | 40.51M | 13.56M | 24.57M | 73.21M |
| Net Cash Flow | 4.62M | -15.04M | 13.84M | -88.80M |
| Free Cash Flow | -35.89M | -28.60M | -9.46M | -46.42M |